<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>44(3)</volume><submitter>Xiong D</submitter><funding>NCI NIH HHS</funding><journal>Cancer communications (London, England)</journal><pagination>448-452</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10958673</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells.</pubmed_title><pmcid>PMC10958673</pmcid><funding_grant_id>R01 CA205633</funding_grant_id><funding_grant_id>R01 CA223804</funding_grant_id><funding_grant_id>R01 CA280746</funding_grant_id><funding_grant_id>R01 CA232433</funding_grant_id><pubmed_authors>Wong ST</pubmed_authors><pubmed_authors>You M</pubmed_authors><pubmed_authors>Hardy M</pubmed_authors><pubmed_authors>Huang M</pubmed_authors><pubmed_authors>Xiong D</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Kalyanaraman B</pubmed_authors><pubmed_authors>Yin Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-25T03:20:09.459Z</modification><creation>2026-06-25T03:08:02.502Z</creation></dates><accession>S-EPMC10958673</accession><cross_references><pubmed>37930151</pubmed><doi>10.1002/cac2.12500</doi></cross_references></HashMap>